VCV001392266.7 - ClinVar

NM_020975.6(RET):c.101A>G (p.Asp34Gly)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(2)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Uncertain significance

criteria provided, multiple submitters, no conflicts

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_020975.6(RET):c.101A>G (p.Asp34Gly)

Variation ID: 1392266 Accession: VCV001392266.7

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 10q11.21 10: 43100486 (GRCh38) [ NCBI UCSC ] 10: 43595934 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Mar 28, 2022	May 1, 2024	Apr 24, 2022

HGVS

Nucleotide	Protein	Molecular consequence
NM_020975.6:c.101A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_066124.1:p.Asp34Gly	missense
NM_000323.2:c.101A>G	NP_000314.1:p.Asp34Gly	missense
NM_001406743.1:c.101A>G	NP_001393672.1:p.Asp34Gly	missense
NM_001406744.1:c.101A>G	NP_001393673.1:p.Asp34Gly	missense
NM_001406759.1:c.101A>G	NP_001393688.1:p.Asp34Gly	missense
NM_001406760.1:c.101A>G	NP_001393689.1:p.Asp34Gly	missense
NM_001406761.1:c.101A>G	NP_001393690.1:p.Asp34Gly	missense
NM_001406762.1:c.101A>G	NP_001393691.1:p.Asp34Gly	missense
NM_001406763.1:c.101A>G	NP_001393692.1:p.Asp34Gly	missense
NM_001406764.1:c.101A>G	NP_001393693.1:p.Asp34Gly	missense
NM_001406765.1:c.101A>G	NP_001393694.1:p.Asp34Gly	missense
NM_001406766.1:c.101A>G	NP_001393695.1:p.Asp34Gly	missense
NM_001406767.1:c.101A>G	NP_001393696.1:p.Asp34Gly	missense
NM_001406768.1:c.101A>G	NP_001393697.1:p.Asp34Gly	missense
NM_001406769.1:c.101A>G	NP_001393698.1:p.Asp34Gly	missense
NM_001406770.1:c.101A>G	NP_001393699.1:p.Asp34Gly	missense
NM_001406771.1:c.101A>G	NP_001393700.1:p.Asp34Gly	missense
NM_001406772.1:c.101A>G	NP_001393701.1:p.Asp34Gly	missense
NM_001406773.1:c.101A>G	NP_001393702.1:p.Asp34Gly	missense
NM_001406774.1:c.101A>G	NP_001393703.1:p.Asp34Gly	missense
NM_001406775.1:c.101A>G	NP_001393704.1:p.Asp34Gly	missense
NM_001406776.1:c.101A>G	NP_001393705.1:p.Asp34Gly	missense
NM_001406777.1:c.101A>G	NP_001393706.1:p.Asp34Gly	missense
NM_001406778.1:c.101A>G	NP_001393707.1:p.Asp34Gly	missense
NM_001406779.1:c.101A>G	NP_001393708.1:p.Asp34Gly	missense
NM_001406780.1:c.101A>G	NP_001393709.1:p.Asp34Gly	missense
NM_001406781.1:c.101A>G	NP_001393710.1:p.Asp34Gly	missense
NM_001406782.1:c.101A>G	NP_001393711.1:p.Asp34Gly	missense
NM_001406783.1:c.101A>G	NP_001393712.1:p.Asp34Gly	missense
NM_001406785.1:c.101A>G	NP_001393714.1:p.Asp34Gly	missense
NM_001406786.1:c.101A>G	NP_001393715.1:p.Asp34Gly	missense
NM_001406787.1:c.101A>G	NP_001393716.1:p.Asp34Gly	missense
NM_001406788.1:c.101A>G	NP_001393717.1:p.Asp34Gly	missense
NM_001406789.1:c.101A>G	NP_001393718.1:p.Asp34Gly	missense
NM_001406790.1:c.101A>G	NP_001393719.1:p.Asp34Gly	missense
NM_001406791.1:c.101A>G	NP_001393720.1:p.Asp34Gly	missense
NM_020629.2:c.101A>G	NP_065680.1:p.Asp34Gly	missense
NM_020630.7:c.101A>G	NP_065681.1:p.Asp34Gly	missense
NC_000010.11:g.43100486A>G
NC_000010.10:g.43595934A>G
NG_007489.1:g.28418A>G
LRG_518:g.28418A>G
LRG_518t1:c.101A>G	LRG_518p1:p.Asp34Gly
LRG_518t2:c.101A>G	LRG_518p2:p.Asp34Gly

... more HGVS ... less HGVS

Protein change

D34G

Other names

Canonical SPDI

NC_000010.11:43100485:A:G

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

dbSNP: rs2132657310 VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
RET		Sufficient evidence for dosage pathogenicity	No evidence available	GRCh38 GRCh37	3598	3720

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Multiple endocrine neoplasia, type 2	Uncertain significance (1)	criteria provided, single submitter	Nov 9, 2021	RCV001896131.5
Hereditary cancer-predisposing syndrome	Uncertain significance (1)	criteria provided, single submitter	Apr 24, 2022	RCV002361178.2

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Uncertain significance (Nov 09, 2021)	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015)) Method: clinical testing	Multiple endocrine neoplasia, type 2 Affected status: unknown Allele origin: germline	Labcorp Genetics (formerly Invitae), Labcorp Accession: SCV002158879.3 First in ClinVar: Mar 28, 2022 Last updated: Feb 20, 2024	Comment: In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant … (more) In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 34 of the RET protein (p.Asp34Gly). (less)
Uncertain significance (Apr 24, 2022)	criteria provided, single submitter (Ambry Variant Classification Scheme 2023) Method: clinical testing	Hereditary cancer-predisposing syndrome Affected status: unknown Allele origin: germline	Ambry Genetics Accession: SCV002663398.2 First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024	Comment: The p.D34G variant (also known as c.101A>G), located in coding exon 2 of the RET gene, results from an A to G substitution at nucleotide … (more) The p.D34G variant (also known as c.101A>G), located in coding exon 2 of the RET gene, results from an A to G substitution at nucleotide position 101. The aspartic acid at codon 34 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. (less)

Comment:

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 34 of the RET protein (p.Asp34Gly).

Comment:

The p.D34G variant (also known as c.101A>G), located in coding exon 2 of the RET gene, results from an A to G substitution at nucleotide position 101. The aspartic acid at codon 34 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for rs2132657310 ...

These citations are identified by LitVar using the rs number, so they may include citations for more than one variant at this location. Please review the LitVar results carefully for your variant of interest.

Record last updated Sep 29, 2024

ClinVar Genomic variation as it relates to human health

NM_020975.6(RET):c.101A>G (p.Asp34Gly)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for rs2132657310 ...